0001567619-19-010316.txt : 20190509 0001567619-19-010316.hdr.sgml : 20190509 20190509171850 ACCESSION NUMBER: 0001567619-19-010316 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190507 FILED AS OF DATE: 20190509 DATE AS OF CHANGE: 20190509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULLIVAN LOUIS W CENTRAL INDEX KEY: 0001193522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 19811820 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN LOUIS DATE OF NAME CHANGE: 20020927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2019-05-07 0 0001367644 Emergent BioSolutions Inc. EBS 0001193522 SULLIVAN LOUIS W 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2019-05-07 4 M 0 7893 13.37 A 56865 D Common Stock 2019-05-07 4 F 0 2135 49.41 D 54730 D Stock Option (Right to Buy) 13.37 2019-05-07 4 M 0 7893 0.0 D 2019-05-16 Common Stock 7893 0 D Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting person's exercise price for the reported stock option exercise. Consists of options granted under the company's stock incentive plan, as amended and restated. The option vested in three equal installments in May 2013, May 2014 and May 2015. Each option represents the right of the reporting person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided by the grant agreement. /s/ S. Scott Lieberman, Attorney-in-fact 2019-05-09